DUPONT CAPITAL MANAGEMENT CORP - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 54 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$700
-59.0%
12,5000.0%0.00%
Q2 2023$1,706
+59.0%
12,5000.0%0.00%
Q1 2023$1,073
+86.6%
12,5000.0%0.00%
Q4 2022$575
-71.2%
12,5000.0%0.00%
Q3 2022$2,000
+100.0%
12,5000.0%0.00%
Q2 2022$1,000
-66.7%
12,5000.0%0.00%
Q1 2022$3,00012,5000.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Q Global Advisors, LLC 195,489$290.02%
MMCAP International Inc. SPC 325,000$47,9050.02%
PERISCOPE CAPITAL INC. 867,072$122,1730.01%
Atalaya Capital Management LP 125,000$18,7500.01%
HGC Investment Management Inc. 200,000$260.01%
COWEN AND COMPANY, LLC 460,987$67,9490.01%
Spartan Fund Management Inc. 507,159$20,9020.01%
EHP Funds Inc. 125,186$17,4440.00%
KIM, LLC 219,800$30,0030.00%
Saba Capital Management, L.P. 756,253$105,3840.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders